Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Pros-IT CNR: an Italian prostate cancer monitoring project.

Noale M, Maggi S, Artibani W, Bassi PF, Bertoni F, Bracarda S, Conti GN, Corvò R, Gacci M, Graziotti P, Magrini SM, Maurizi Enrici R, Mirone V, Montironi R, Muto G, Pecoraro S, Porreca A, Ricardi U, Tubaro A, Zagonel V, Zattoni F, Crepaldi G; Pros-IT CNR study group.

Aging Clin Exp Res. 2017 Apr;29(2):165-172. doi: 10.1007/s40520-017-0735-6. Epub 2017 Feb 24.

PMID:
28236267
2.

Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?

Agolli L, Maurizi Enrici R, Osti MF.

World J Gastroenterol. 2016 Jan 21;22(3):1131-8. doi: 10.3748/wjg.v22.i3.1131. Review.

3.

Renin-Angiotensin System Inhibitors Might Help to Reduce the Development of Symptomatic Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer.

Bracci S, Valeriani M, Agolli L, De Sanctis V, Maurizi Enrici R, Osti MF.

Clin Lung Cancer. 2016 May;17(3):189-97. doi: 10.1016/j.cllc.2015.08.007. Epub 2015 Aug 29.

PMID:
26427647
4.

Radiation oncology in Italy: the past, the present, the future.

Maurizi Enrici R, De Sanctis V.

Int J Radiat Oncol Biol Phys. 2015 Mar 15;91(4):692-6. doi: 10.1016/j.ijrobp.2014.12.016. No abstract available.

PMID:
25752379
5.

Image guided intensity modulated hypofractionated radiotherapy in high-risk prostate cancer patients treated four or five times per week: analysis of toxicity and preliminary results.

Valeriani M, Carnevale A, Osti MF, DE Sanctis V, Agolli L, Maurizi Enrici R.

Radiat Oncol. 2014 Sep 26;9:214. doi: 10.1186/1748-717X-9-214.

6.

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.

Cicone F, Minniti G, Romano A, Papa A, Scaringi C, Tavanti F, Bozzao A, Maurizi Enrici R, Scopinaro F.

Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):103-11. doi: 10.1007/s00259-014-2886-4. Epub 2014 Aug 15.

PMID:
25182751
7.

Manipulation of radiation-induced bystander effect in prostate adenocarcinoma by dose and tumor differentiation grade: in vitro study.

Tubin S, Valeriani M, Salerno G, Bracci S, Stoppacciaro A, Cardelli P, Osti MF, De Sanctis V, Minniti G, Maurizi Enrici R.

Int J Radiat Biol. 2015 Feb;91(2):166-71. doi: 10.3109/09553002.2015.959667. Epub 2015 Jan 29.

PMID:
25174735
8.

Image-guided hypofractionated radiotherapy in low-risk prostate cancer patients.

Valeriani M, Carnevale A, Agolli L, Bonome P, Montalto A, Nicosia L, Osti MF, De Sanctis V, Minniti G, Maurizi Enrici R.

Biomed Res Int. 2014;2014:465175. doi: 10.1155/2014/465175. Epub 2014 Apr 23.

9.

Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients.

Osti MF, Agolli L, Bracci S, Masoni L, Valeriani M, Falco T, De Sanctis V, Maurizi Enrici R.

Int J Colorectal Dis. 2014 Jul;29(7):835-42. doi: 10.1007/s00384-014-1879-x. Epub 2014 May 14.

PMID:
24825722
10.

Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.

Osti MF, Carnevale A, Valeriani M, De Sanctis V, Minniti G, Cortesi E, Martelli M, Maurizi Enrici R.

Clin Lung Cancer. 2013 Nov;14(6):699-703. doi: 10.1016/j.cllc.2013.06.006. Epub 2013 Jul 22.

PMID:
23886798
11.

Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.

Minniti G, Esposito V, Clarke E, Scaringi C, Lanzetta G, Salvati M, Raco A, Bozzao A, Maurizi Enrici R.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):623-9. doi: 10.1016/j.ijrobp.2013.03.037. Epub 2013 May 15.

PMID:
23683828
12.

[Curative radiotherapy in patients with anal cancer: clinical outcomes and prognostic factors in a single-institution experience].

Osti MF, Agolli L, Scaringi C, Bracci S, Minniti G, Maurizi Enrici R.

Radiol Med. 2013 Aug;118(5):882-94. doi: 10.1007/s11547-012-0900-0. Epub 2012 Nov 26. Italian.

PMID:
23184242
13.

External-beam radiotherapy and/or HDR brachytherapy in postoperative endometrial cancer patients: clinical outcomes and toxicity rates.

De Sanctis V, Agolli L, Valeriani M, Narici S, Osti MF, Patacchiola F, Mossa B, Moscarini M, Maurizi Enrici R.

Radiol Med. 2013 Mar;118(2):311-22. doi: 10.1007/s11547-012-0833-7. Epub 2012 May 14.

PMID:
22580814
14.

Stereotactic Irradiation of GH-Secreting Pituitary Adenomas.

Minniti G, Scaringi C, Amelio D, Maurizi Enrici R.

Int J Endocrinol. 2012;2012:482861. doi: 10.1155/2012/482861. Epub 2012 Feb 22.

15.

Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy.

Valeriani M, Muni R, Osti MF, De Sanctis V, Minniti G, Ardito F, Maurizi Enrici R.

Radiol Med. 2012 Feb;117(1):125-32. doi: 10.1007/s11547-011-0716-3. Epub 2011 Sep 2. English, Italian.

PMID:
21892718
16.

Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide.

Minniti G, Salvati M, Arcella A, Buttarelli F, D'Elia A, Lanzetta G, Esposito V, Scarpino S, Maurizi Enrici R, Giangaspero F.

J Neurooncol. 2011 Apr;102(2):311-6. doi: 10.1007/s11060-010-0324-4. Epub 2010 Aug 5.

PMID:
20686820
17.

Subjective and objective measures of late genitourinary morbidity following hypofractionated radiotherapy in men with prostate cancer.

Tombolini V, Di Staso M, Bonfili P, Di Genesio Pagliuca M, Franzese P, Buonopane S, Valeriani M, Maurizi Enrici R, Festuccia C, Gravina GL.

Prostate Cancer Prostatic Dis. 2010 Mar;13(1):34-8. doi: 10.1038/pcan.2009.23. Epub 2009 Jun 23.

PMID:
19546884
18.

Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma.

Minniti G, De Sanctis V, Muni R, Rasio D, Lanzetta G, Bozzao A, Osti MF, Salvati M, Valeriani M, Cantore GP, Maurizi Enrici R.

J Neurooncol. 2009 Jan;91(1):95-100. doi: 10.1007/s11060-008-9689-z. Epub 2008 Aug 29.

PMID:
18758912
19.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.

Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, Osti MF, De Paula U, Lanzetta G, Tombolini V, Maurizi Enrici R.

J Neurooncol. 2008 May;88(1):97-103. doi: 10.1007/s11060-008-9538-0. Epub 2008 Feb 5.

PMID:
18250965
20.

Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed + oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy.

Valentini V, Coco C, Minsky BD, Gambacorta MA, Cosimelli M, Bellavita R, Morganti AG, La Torre G, Trodella L, Genovesi D, Portaluri M, Maurizi-Enrici R, Barbera F, Maranzano E, Lupattelli M.

Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):403-12. Epub 2007 Oct 4.

PMID:
17919844
21.

Long-term follow-up results of postoperative radiation therapy for Cushing's disease.

Minniti G, Osti M, Jaffrain-Rea ML, Esposito V, Cantore G, Maurizi Enrici R.

J Neurooncol. 2007 Aug;84(1):79-84. Epub 2007 Mar 14.

PMID:
17356896
22.

Local recurrence in breast cancer after conservative surgery: timing of radiotherapy and sequencing of chemotherapy.

Donato V, Monaco A, Messina F, De Sanctis V, Messineo D, Banelli E, Maurizi Enrici R.

Anticancer Res. 2004 Mar-Apr;24(2C):1303-6.

23.

TRUS staging and follow-up in patients with anal canal cancer.

Drudi FM, Raffetto N, De Rubeis M, Santarelli M, Padula S, Mendicino P, Maurizi Enrici R, Passariello R.

Radiol Med. 2003 Oct;106(4):329-37. English, Italian.

PMID:
14612825
24.

Hodgkin's disease of the nasopharynx: diagnostic and therapeutic approach with a review of the literature.

Anselmo AP, Cavalieri E, Cardarelli L, Gianfelici V, Osti FM, Pescarmona E, Maurizi Enrici R.

Ann Hematol. 2002 Sep;81(9):514-6. Epub 2002 Sep 13. Review.

PMID:
12373352
25.

Technetium-99m tetrofosmin imaging in malignant lymphomas.

Schillaci O, Filippis AM, Anselmo AP, Monteleone F, Capoccetti F, Massa R, Maurizi Enrici R, Scopinaro F.

Tumori. 2002 May-Jun;88(3):S24-5.

PMID:
12365376
26.

Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease.

Anselmo AP, Cavalieri E, Meloni G, Alimena G, Cantonetti M, Maurizi Enrici R, Tosti ME, Falchetto Osti M, Gianfelici V, Mandelli F.

Haematologica. 2002 May;87(5):507-11.

27.

Successful pregnancies following an egg donation program in women with previously treated Hodgkin's disease.

Anselmo AP, Cavalieri E, Aragona C, Sbracia M, Funaro D, Maurizi Enrici R.

Haematologica. 2001 Jun;86(6):624-8.

28.

[The radiotherapeutic treatment of rectal tumors in the elderly patient over 70].

Donato V, Scalabrino G, Costa AM, Santarelli M, Banelli E, Maurizi Enrici R.

Minerva Med. 1999 Jul-Aug;90(7-8):229-31. Italian. No abstract available.

PMID:
10719425
29.

The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.

Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.

Haematologica. 1998 Sep;83(9):812-23.

30.

[Computerized tomography and magnetic resonance in radical and reconstructive surgery using pedunculated and revascularized flaps in advanced-stage tumors of the head and neck. Analysis of recurrences. II].

Falchetto Osti M, Scattoni Padovan F, Sbarbati S, Ricciardi D, De Angelis D'Ossat M, Maurizi Enrici R.

Radiol Med. 1998 Apr;95(4):315-21. Italian.

PMID:
9676209
31.

[Anatomic changes after radical surgery and reconstruction with pedunculated or revascularized flaps in advanced head and neck tumors: computerized tomography and magnetic resonance findings].

Osti MF, Scattoni Padovan F, Ricciardi D, De Angelis D'Ossat M, Sbarbati S, Pirolli C, Maurizi Enrici R, Anaveri G.

Radiol Med. 1997 Apr;93(4):352-7. Italian.

PMID:
9244910
32.

Acute nonlymphocytic leukemia: onset after treatment for Hodgkin's disease.

Maurizi Enrici R, Anselmo AP, Osti MF, Santoro M, Sbarbati S, Tombolini V, Mandelli F, D'Arcangelo E, Biagini C.

Ann Hematol. 1997 Mar;74(3):103-10.

PMID:
9111422
33.

Analysis of the risk of solid tumor following Hodgkin's disease.

Maurizi Enrici R, Anselmo AP, Osti MF, Santoro M, Tombolini V, Mandelli F, Biagini C.

Haematologica. 1997 Jan-Feb;82(1):57-63.

34.

[Gastric adenocarcinoma: magnetic resonance versus surgical staging].

Costanzi A, Di Cesare E, Guadagni S, Masciocchi C, De Bernardinis G, Maurizi Enrici R.

Radiol Med. 1996 Dec;92(6):726-30. Italian.

PMID:
9122461
35.

Meningeal localization in a patient with Hodgkin's disease. Description of a case and review of the literature.

Anselmo AP, Proia A, Cartoni C, Baroni CD, Maurizi Enrici R, Delfini R, Avvisati G.

Ann Oncol. 1996 Dec;7(10):1071-5. Review.

PMID:
9037367
36.

Supratentorial glioblastoma: neuroradiological findings and survival after surgery and radiotherapy.

Pierallini A, Bonamini M, Osti MF, Pantano P, Palmeggiani F, Santoro A, Maurizi Enrici R, Bozzao L.

Neuroradiology. 1996 May;38 Suppl 1:S26-30.

PMID:
8811675
37.

[Assessment of residual mediastinal tumor in patients with Hodgkin's lymphoma using computed tomography, magnetic resonance and 67Ga scintigraphy].

Capua A, Osti MF, Scattoni Padovan F, Sarra R, Sbarbati S, Anselmo AP, Maurizi Enrici R.

Radiol Med. 1995 Dec;90(6):797-803. Italian.

PMID:
8685466
38.

[Comparison of computerized tomography and magnetic resonance in staging of T and N parameters in head and neck neoplasms].

Falchetto Osti M, Maurizi Enrici R, Scattoni Padovan F, Minnetti M, Sbarbati S, Pirolli C, Anaveri G.

Radiol Med. 1995 Oct;90(4):396-403. Italian.

PMID:
8552815
39.

[Hodgkin's disease in stages I and IIA. Analysis of results in a group of patients with a follow-up of at least 10 years treated at the onset of the disease with radiotherapy alone].

Maurizi Enrici R, Falchetto Osti M, Anselmo AP, Tombolini V, Cartoni C, Scattoni Padovan F, Sbarbati S, Cavaceppi P, Biagini C.

Radiol Med. 1995 Jun;89(6):855-60. Italian.

PMID:
7644742
40.

[The radiology of cerebral and paranasal sinus fungal lesions].

Donato V, Capua A, Cardello P, Pompili E, Tombolini V, Maurizi Enrici R, Martino P.

Radiol Med. 1994 Nov;88(5):559-63. Italian.

PMID:
7824768
41.

[Computed tomography in the preoperative staging of gastric cancer].

Potente G, Osti MF, Torriero F, Scattoni Padovan F, Maurizi Enrici R.

Radiol Med. 1994 Jan-Feb;87(1-2):76-81. Italian.

PMID:
8128037
42.

[Role of computed tomography in the follow-up of patients treated with radical surgery and reconstruction with myocutaneous flap for head and neck tumors in advanced stage].

Osti MF, De Vincentiis M, Minni A, Potente G, Scattoni Padovan F, Torriero F, Maurizi Enrici R.

Radiol Med. 1993 Apr;85(4):402-5. Italian.

PMID:
8516466
43.

[Desmoid tumor of the anterior abdominal wall. A case report].

Potente G, Osti MF, Torriero F, Scattoni Padovan F, Maurizi Enrici R.

Radiol Med. 1993 Jan-Feb;85(1-2):142-3. Italian. No abstract available.

PMID:
8480043
44.

Combined modality (ABVD plus radiotherapy) versus radiotherapy in the management of early stage (IIA) Hodgkin's disease with mediastinal involvement.

Anselmo AP, Bove M, Cartoni C, Damico C, Maurizi Enrici R, Falchetto Osti M, Biagini C.

Haematologica. 1992 Mar-Apr;77(2):177-9.

PMID:
1383107
45.

[Role of radiotherapy in the treatment of seminoma of the testis].

Tombolini V, Capua A, Grapulin L, Maurizi Enrici R, Osti MF, Sarra R.

Radiol Med. 1991 Sep;82(3):334-8. Italian.

PMID:
1947271
46.

[Evolution of the diagnostic accuracy of CT in clinical staging of patients with Hodgkin's disease].

Maurizi Enrici R, Anselmo AP, Campodonico F, Capua A, Osti MF, Sarra R, Tombolini V.

Radiol Med. 1991 Apr;81(4):464-8. Italian.

PMID:
2028039
47.

[Radiotherapy in the treatment of tumors of the nasopharynx in advanced stage].

Donato V, Maurizi Enrici R, Banelli E, Cerqua M, Falchetto Osti M, Santarelli M, Vitturini A.

Radiol Med. 1990 Oct;80(4):506-9. Italian.

PMID:
2244040
48.

Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs ABVD/MOPP.

Anselmo AP, Cartoni C, Bellantuono P, Maurizi-Enrici R, Aboulkair N, Ermini M.

Haematologica. 1990 Mar-Apr;75(2):155-8.

PMID:
1694156
49.

MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.

Cimino G, Biti GP, Anselmo AP, Maurizi Enrici R, Bellesi GP, Bosi A, Cionini L, Mungai V, Papa G, Ponticelli P, et al.

J Clin Oncol. 1989 Jun;7(6):732-7.

PMID:
2715803
50.

Treatment of uncertainty in an oncology protocol by probabilistic and artificial intelligence approaches.

de Rosis F, Steve G, Biagini C, Maurizi-Enrici R.

Methods Inf Med. 1988 Feb;27(1):23-33. No abstract available.

PMID:
3347161

Supplemental Content

Loading ...
Support Center